PeptideStack
5.2kquestions
20kanswers
220users

I want to move my injection day. How much drift does the label actually allow, and in which direction?

Asked 20 May 2025Modified 13 months agoViewed 21k times
21

My weekly dose currently lands on a Thursday and that is now the worst day of my week for it. I want it on a Sunday. That is a three-day move and I can see two ways to make it:

  • Shorten once. Go Thursday, then the following Sunday — a four-day interval — and weekly after that.
  • Lengthen once. Go Thursday, then the Sunday ten days later, and weekly after that.
  • Or drift. Move it by one day a week for three weeks, so intervals of 6, 6, 6 days.

The labels permit a day change subject to a minimum interval, so all three appear to be allowed on paper. But allowed and equivalent are different things, and I would like to know which perturbation is smaller and why. Ideally with the exposure arithmetic, because I suspect the two directions are not symmetric and I cannot see immediately which way round it goes.

missed-dose
missed-dose

What the label instructions for a missed weekly dose are, why they differ between agents, and what the pharmacokinetics say about drift in an…

41 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

162 questions
shareeditfollowflag
TM
askedtwo_two_micron15k1720 May 2025
4They are not symmetric, and the asymmetry is a property of exponential decay rather than of the drug. – kwn_analytical 4 months ago
add a comment

3 Answers

Accepted answer first, then by votes
62

Accepted answer

Lengthening is the smaller perturbation, and the asymmetry is arithmetic rather than pharmacological. Working your three options for a 7-day-half-life weekly agent at steady state, with peak 2.000 and trough 1.000 in units of one dose.

Option 1 — shorten once, 4-day interval

  1. Thursday dose taken: level 2.000.
  2. Four days later: 2.000 × 2^(−4/7) = 2.000 × 0.6716 = 1.343.
  3. Sunday dose: 2.343. That is +17 % on the normal peak.
  4. Then weekly. Excess decays by half each week: 2.343 → 1.171 → 2.171 → 1.086 → 2.086 → 1.043 → 2.043. Within 2 % after three weeks.

Option 2 — lengthen once, 10-day interval

  1. Thursday dose taken: level 2.000.
  2. Ten days later: 2.000 × 2^(−10/7) = 2.000 × 0.3720 = 0.744. That is 26 % below the normal trough, and the low point lasts three days.
  3. Sunday dose: 1.744, which is 13 % below the normal peak.
  4. Then weekly: 1.744 → 0.872 → 1.872 → 0.936 → 1.936. Within 3 % after two weeks.

Option 3 — drift, three 6-day intervals

  1. Level after 6 days: 2.000 × 2^(−6/7) = 2.000 × 0.5518 = 1.104. Dose: 2.104, or +5 %.
  2. Next 6 days: 2.104 × 0.5518 = 1.161. Dose: 2.161, +8 %.
  3. Third: 2.161 × 0.5518 = 1.193. Dose: 2.193, +10 %.
  4. Then back to 7-day intervals: 2.193 → 1.097 → 2.097 → 1.048 → 2.048. Settles in two weeks.

The comparison

ApproachWorst deviation from normal peakWorst deviation from normal troughWeeks to settleNumber of irregular intervals
Shorten once, 4 days+17 %noneabout 31
Lengthen once, 10 days−13 %−26 %about 21
Drift, three 6-day intervals+10 %noneabout 23

So the drift produces the smallest single deviation, at the cost of three weeks of irregular schedule and three opportunities to lose track of where you are. Shortening produces a larger overshoot than lengthening produces an undershoot at the peak, but lengthening puts a deeper dip in the trough. Nothing here is dramatic — every number in that table sits inside the exposure variability between two people on the same dose.

Why the asymmetry exists

Because decay is exponential and dosing is additive. Shortening the interval means the previous dose has decayed less, so more of it is still present when you add a whole new dose — the additive term is fixed at 1.000 regardless, and the residual term is what varies. Lengthening lets the residual decay further, and the dose you add cannot subtract anything. So the peak can only be pushed up by a full dose unit at most, while the trough can be pushed down towards zero without limit. Shortening has a bounded effect on the peak; lengthening has an unbounded effect on the trough, and past a couple of weeks the trough effect becomes the dominant one.

Which is the general principle behind every rule in this class: the labels are more permissive about compressing an interval slightly than about extending it indefinitely, and the missed-dose instructions are written so that the answer to "may I take it late" is yes within a window and the answer to "may I skip it" is a shrug.

The constraint to check

All three of your options respect the label minimum interval for a 7-day-half-life weekly agent, since 4 days and 6 days both exceed 48 hours comfortably. For an agent whose label specifies 72 hours the same options are also fine. The option that is not fine is the impatient version — move the day by moving this week's dose to two days ago, which is not a thing that can be done, or to tomorrow when the next scheduled dose is the day after. As always, the label being dosed from is the authority and a clinician is the right person to ask about a schedule change.

shareimprove this answerflag
TW
answered · acceptedtamsin_wray13k1714 Jul 2025
Bounded above, unbounded below. That is the cleanest statement of why these two directions are not mirror images. – Dr_Elias_Weiss 9 months ago
8Three irregular intervals is three chances to make a bookkeeping error, which in practice is the larger risk than a 7 % exposure difference. – ravenna_pace 7 months ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
25

A reason to prefer the single-step approaches over the drift that has nothing to do with exposure: a drifting schedule destroys your ability to attribute symptoms.

People on this class typically develop a reproducible weekly symptom pattern — some describe a first-48-hours effect, some a mid-week trough in appetite suppression, some nothing at all. Whatever the pattern, its value is that it is stable, because a stable pattern lets you notice a change. A new symptom appearing on day 3 is informative if day 3 has looked the same for eleven weeks.

During three weeks of drift, the day of the week and the day of the cycle are both moving, and you have lost the ability to distinguish "this is the day-3 effect" from "this is a Wednesday effect" from "this is new". If anything goes wrong during a drift, the drift is a confounder you introduced yourself.

Practical version of the argument: make the change once, on a week where nothing else is changing, and hold everything else constant across it. Not simultaneously with an escalation, not in the week of a new vial, not while travelling across time zones. One variable at a time is not a fussy laboratory principle here, it is the only way a weekly cycle with a sample size of one is interpretable at all.

On the direction, I mildly disagree with the accepted answer's framing on practical rather than arithmetic grounds. Shortening once means the change is complete immediately and the following week is already normal. Lengthening once means a three-day stretch where exposure is at its lowest point in the whole schedule, and for anyone whose appetite signal is noticeably time-varying across a normal week, that stretch is the part of the week they will notice most. The arithmetic favours lengthening by a few percentage points; the experience reported by people who have moved a day tends to favour getting it over with. Both are inside the label. Neither is a decision this board should be making for anyone.

shareimprove this answerflag
DB
answeredDr_Fatima_Belkacem52k1383 Jul 2025
8

Time zones, since the question is really about calendars and nobody has raised the case that actually catches people out.

Crossing time zones changes the clock but not the elapsed time. Flying east across eight hours and dosing "same day, same local time" is a 16-hour-shorter interval; flying west is 32 hours longer if you also keep the same nominal weekday. Neither of these is remotely enough to matter for a 7-day-half-life agent — a 16-hour compression on a 168-hour interval is a 10 % interval change, producing about a 3 % peak change by the arithmetic above.

What does matter, and only for the cold-chain question rather than the pharmacokinetics, is that a long trip converts a refrigerated storage problem into an ambient one. That is a different discussion, but it is the reason travel weeks are the weeks people actually get wrong: not because of the schedule, because of the logistics.

One genuinely useful convention if you travel often: track the schedule in elapsed days from the last administration rather than in weekdays. A weekday is a label on a calendar; the drug responds to elapsed hours. Once you are counting elapsed days, a time-zone shift becomes visibly irrelevant and a genuine two-day slip becomes visible instead of hiding behind the fact that it is still nominally Thursday.

shareimprove this answerflag
TN
answeredtabular_nums47k3822 Jun 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.